Concepedia

Publication | Open Access

Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1

557

Citations

26

References

2020

Year

Abstract

NCT02437318.

References

YearCitations

Page 1